← Evidence map

ArticleAmerican journal of epidemiology2023

RE: "RISK AND BENEFIT OF mRNA COVID-19 VACCINES FOR THE OMICRON VARIANT BY AGE, SEX, AND PRESENCE OF COMORBIDITY: A QUALITY-ADJUSTED LIFE YEARS ANALYSIS".

Amnuay Kleebayoon et al.PubMed ↗Publisher ↗

No numbers read from the abstract.

Not cited yet

RE: "RISK AND BENEFIT OF mRNA COVID-19 VACCINES FOR THE OMICRON VARIANT BY AGE, SEX, AND PRESENCE OF COMORBIDITY: A QUALITY-ADJUSTED LIFE YEARS ANALYSIS". | OpenQuestion